Glycated haemoglobin (HbA1c) IVD, control
- Device ID
- 89821
- MHRA Reference Number
- 89821
- Date Registered
- Nov 26, 2024
- Last Updated
- Nov 15, 2024
- Device Type
- In Vitro Diagnostic Device
- Devices
- Glycated haemoglobin (HbA1c) IVD, control
- Type
- IVD General
- Address
- Kjelsasveien 161 P.O. Box 6863 Rodelokka Oslo, Norway
- Created Date
- Jul 21, 2021
- Relationship Type
- UK Responsible Person
- Address
- Abbott House Vanwall Road Vanwall Business Park Maidenhead, Windsor And Maidenhead, England, United KingdomPostcode: SL6 4XE
Devices with a matching generic name or device type registered with MHRA
Additional devices registered by the same manufacturer
Additional devices represented by Unipath Limited (trading as Alere International) in the UK
Glycated haemoglobin (HbA1c) IVD, control is a medical device registered with the UK's Medicines and Healthcare products Regulatory Agency (MHRA) under Device ID 89821. The device is manufactured by Abbott Diagnostics Technologies AS from Norway, classified as In Vitro Diagnostic Device. The authorized representative in the UK is Unipath Limited (trading as Alere International).
This page provides comprehensive regulatory information including complete registration details, manufacturer information, device classification, authorized representative details, and related products. Pure Global AI offers free access to 150,962+ UK MHRA medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.